InMed Pharmaceuticals's total assets for Q4 2026 were C$3.03M, a decrease of -66.83% from the previous quarter. DE:MWG total liabilities were C$1.96M for the fiscal quarter, a -12.80% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.